"Evaluation of Safety and Pharmacokinetics of Administering Intravenous Busulfan in a Twice-daily or Daily Schedule to Patients with Advanced Hematologic Malignant Disease Undergoing Stem Cell Transplantation." by Hugo F Fernandez

Article

Evaluation of Safety and Pharmacokinetics of Administering Intravenous Busulfan in a Twice-daily or Daily Schedule to Patients with Advanced Hematologic Malignant Disease Undergoing Stem Cell Transplantation.

Biology of Blood and Marrow Transplantation (2002)

Hugo F Fernandez, University of Miami
Hai T Tran
Federico Albrecht, University of Miami
Shari Lennon, University of Miami
Humberto Caldera, University of Miami
Mark S Goodman, University of Miami

Link

Disciplines

Publication Date

January 9, 2002

DOI

10.1053/bbmt.2002.v8.pm12374453

Citation Information

Hugo F Fernandez, Hai T Tran, Federico Albrecht, Shari Lennon, et al.. "Evaluation of Safety and Pharmacokinetics of Administering Intravenous Busulfan in a Twice-daily or Daily Schedule to Patients with Advanced Hematologic Malignant Disease Undergoing Stem Cell Transplantation." Biology of Blood and Marrow Transplantation Vol. 8 Iss. 9 (2002) p. 486 - 492
Available at: http://works.bepress.com/federico-albrecht/1/